OpenVSafe by OpenVAERS
Search V-safe

L5M-26948-09996

2 vaccinations 4 coded responses 4 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
029 / RI
Registered
2022-02-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-01-14
    Dose 1 — Moderna
  2. 2022-02-11
    Dose 2 — Moderna
  3. 2022-02-12
    Registered in v-safe
  4. 2022-02-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Heart rate increased — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Faster resting heart rate
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-02-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Heart rate increased, Hyperhidrosis — Feeling: Fair · Site: Pain
    Free text: Sweating and faster than normal resting heart rate.
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-02-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Heart rate increased — Feeling: Good · Site: Pain
    Free text: Still a slight rise in resting heart rate
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-02-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Blood pressure increased, Heart rate abnormal — Feeling: Good · Site: Pain
    Free text: Heart rate back to normal. Elevation in BP
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12022-01-14Moderna No
22022-02-11Moderna No

Free text

Release 11 — days 1–6 daily, dose 2

2022-02-12

Systemic reaction (other): Faster resting heart rate

2022-02-13

Systemic reaction (other): Sweating and faster than normal resting heart rate.

2022-02-14

Systemic reaction (other): Still a slight rise in resting heart rate

2022-02-16

Systemic reaction (other): Heart rate back to normal. Elevation in BP

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROBlood pressure increased · · ✓
SROHeart rate abnormal · · ✓
SROHeart rate increased · · ✓
SROHyperhidrosis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release